2m 2m 2m 2m 2m 2m 2m
Ligand Pharma (LGND)
NASDAQ
$309.39+$0.14 (+0.04%)
Price as of Jul 14, 2026 8:37 AM EDT- $6.2BMarket Cap
- 143.66%1-Year Change
- BiotechnologyIndustry
Ligand Pharma (LGND)
$309.39+$0.14 (+0.04%)
Earnings Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 19.29% | ||
12-Month Momentum | 103.98% | ||
3-Month Risk Adjusted Momentum | 99.38% | ||
12-Month Risk Adjusted Momentum | 294.69% |
True Yield
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.38% | ||
Net Debt Paydown Yield | -0.60% |
Financial Health Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |